FdaApplication
NDA 212122
Identifiers
- fda_app_no: NDA212122
Properties
| Property | Value |
|---|---|
| applicant_name | ASTRAZENECA AB |
| application_type | NDA |
| approval_date | 2020-07-23 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BREZTRI AEROSPHERE | BUDESONIDE; FORMOTEROL FUMARATE; GLYCOPYRROLATE | 0.16MG/INH;0.0048MG/INH;0.009MG/INH | AEROSOL, METERED;INHALATION |
| BREZTRI AEROSPHERE | BUDESONIDE; FORMOTEROL FUMARATE; GLYCOPYRROLATE | 0.16MG/INH;0.0048MG/INH;0.018MG/INH | AEROSOL, METERED;INHALATION |
2 products